Effects of growth hormone treatment on arginine to asymmetric dimethylarginine ratio and endothelial function in patients with growth hormone deficiency

Metabolism: Clinical and Experimental

Volumn 57, Issue 12, 2008, Pages 1685-1690

  Setola, Emanuela ^a   Monti, Lucilla D ^a   Lanzi, Roberto ^a   Lucotti, Pietro ^a   Losa, Marco ^a   Gatti, Elisa ^a   Galluccio, Elena ^a   Oldani, Matteo ^a   Fermo, Isabella ^a   Giovannelli, Massimo ^a   Bosi, Emanuele ^a   Piatti, PierMarco ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC GMP; GROWTH HORMONE; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRIC OXIDE; NITRITE; SOMATOMEDIN C;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; FEMALE; FOREARM BLOOD FLOW; GLUCOSE METABOLISM; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL;

ADIPOSITY; ADOLESCENT; ADULT; ARGININE; BODY WEIGHT; ENDOTHELIUM, VASCULAR; FEMALE; GROWTH DISORDERS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; MALE; MIDDLE AGED; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 55649091391     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.07.024     Document Type: Article

References (35)

1. Rosen T., and Bengtsson B.A. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336 (1990) 285-288
2. Bulow B., Hagmar L., Mikoczy Z., et al. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol 46 (1997) 75-81
3. Colao A., Di Somma C., Savanelli M.C., et al. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res 16 (2006) S41-S48
4. Colao A., Di Somma C., Filippella M., et al. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 61 (2004) 360-366
5. Capaldo B., Guardatole V., Pardo F., et al. Abnormal vascular reactivity in growth hormone deficiency. Circulation 103 (2001) 520-524
6. Boger R.H., Skamira C., Bode-Boger S.M., et al. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. a double blind, placebo-controlled study. J Clin Invest 98 (1996) 2706-2713
7. Ren J., Duan J., Thomas D.P., et al. IGF-1 alleviates diabetes induced RhoA activation, eNOS uncoupling, and myocardial dysfunction. J Physiol Regul Integr Comp Physiol 294 (2008) R793-R802
8. Miyazaki H., Matsuoka H., and Cooke J.P. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99 (1999) 1141-1146
9. Druhan L.J., Forbes S.P., Pope A.J., et al. Regulation of eNOS-derived superoxide by endogenous methylarginines. Biochemistry (2008) [Epub ahead of print]
10. Krzyzanowska K., Mittermayer F., Schnack C., et al. Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency. Eur J Clin Invest 35 (2005) 208-213
11. Valkonen V.P., Paiva H., Salonen J.T., et al. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358 (2001) 2127-2128
12. Leiper J., and Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43 (1999) 542-548
13. Takiuchi S., Fujii H., Kamide K., et al. Plasma asymmetric dimethylarginine and coronary and peripheral endothelial dysfunction in hypertensive patients. J Hypertens 9 (2004) 802-808
14. Thum T., Fleissner F., Klink I., et al. Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. J Clin Endocrinol Metab 92 (2007) 4172-4179
15. Colao A., Cerbone G., Pivonello R., et al. growth hormone (GH) response to the arginine plus GH-releasing hormone test is correlated to the severity of lipid profile abnormalities in adult patients with GH deficiency. J Clin Endocrinol Metab 84 (1999) 1277-1282
16. Forte P., Copland M., Smith L.M., et al. Basal nitric oxide synthesis in essential hypertension. Lancet 349 (1997) 837-842
17. Setola E., Monti L.D., Galluccio E., et al. Insulin resistance and endothelial function are improved after folate and vitamin B12 therapy in patients with the metabolic syndrome: relationship between homocysteine levels and hyperinsulinemia. Eur J Endocrinol 151 (2004) 483-489
18. Alomari M.A., Solomito A., Reyes R., et al. Measurements of vascular function using strain-gauge plethysmography: technical considerations, standardization, and physiological findings. J Physiol Heart Circ Physiol 286 (2004) H99-H487
19. Irace C., Ceravolo R., Notarangelo L., et al. Comparison of endothelial function evaluated by strain gauge plethysmography and brachial artery ultrasound. Atherosclerosis 158 (2001) 53-59
20. Pi J., Kumagai Y., Sun G., et al. Improved method for simultaneous determination of l-arginine and its mono- and dimethylated metabolites in biological samples by high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 742 (2000) 199-4803
21. Boger R.H. Asymmetric dimethylarginine (ADMA) modulates endothelial function-therapeutic implications. Vasc Med 8 (2003) 149-151
22. Cooke J.P. Asymmetrical dimethylarginine: the Über marker?. Circulation 109 (2004) 1813-1819
23. Zoccali C., Bode-Boger S., Mallamaci F., et al. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358 (2001) 2113-2117
24. Yoo J.H., and Lee S.C. Elevated levels of plasma homocysteine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158 (2001) 425-430
25. Bode-Böger S.M., Böger R.H., Kienke S., et al. Elevated l-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary l-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219 (1996) 598-603
26. Böger R.H., Bode-Böger S.M., Thiele W., et al. Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease. J Am Coll Cardiol 32 (1998) 1336-1344
27. Bode-Böger S.M., Scalera F., and Ignarro L.J. l-arginine paradox: importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ter 114 (2007) 295-296
28. Dierkes J., Westphal S., Martens-Lobenhoffer J., et al. Fenofibrate increases the l-arginine:ADMA ratio by increases of l-arginine concentration but has no effect on ADMA concentration. Atherosclerosis 173 (2004) 239-244
29. Smith J.C., Evans L.M., Wilkinson I., et al. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf) 56 (2002) 493-501
30. Osterziel K.J., Bode-Böger S.M., Strohm O., et al. Role of nitric oxide in the vasodilator effect of recombinant human growth hormone in patients with dilated cardiomyopathy. Cardiovasc Res 45 (2000) 447-453
31. Evans L.M., Davies J.S., Anderson R.A., et al. effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 142 (2000) 254-262
32. Wickman A., Jonsdottir H., Bergstrom G., et al. GH and IGF-1 regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissue of hypophysectomized female rats. Eur J Endocrinol 147 (2002) 523-533
33. Napoli R., Guardasole V., Angelini V., et al. Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab 88 (2003) 2817-2820
34. Gotherstrom G., Bengtsson B.A., Bosaeus I., et al. 10-year, prospective study of the metabolic effects of growth hormone replacement in adults. J Clin Endocrinol Metab 92 (2007) 1442-1445
35. Colao A., Di Somma C., Spiezia S., et al. natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis. J Clin Endocrinol Metab 91 (2006) 2191-2200